EHA24: LBA – Potential Frontline Treatment for Elderly Patients with Untreated Mantle Cell Lymphoma
Just released at this year’s EHA congress, this late-breaking abstract shows the promising efficacy and safety of acalabrutinib combined with bendamustine and rituximab for elderly patients with untreated mantle cell lymphoma.